There were 2,379 press releases posted in the last 24 hours and 440,345 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and Obesity

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image